RBSH OTC
Rebus Holdings, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -98.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0001
Volume33,943
Avg Volume1,283
Beta10.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORaul Silvestre
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2009-11-04
Websiterebus-corp.com
2629 Townsgate Road
Westlake Village, CA 91361
US
Westlake Village, CA 91361
US
818 597 7552
About Rebus Holdings, Inc.
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found